DENTSPLY SIRONA Inc (XRAY) Expected to Post Earnings of $0.54 Per Share

Equities analysts expect that DENTSPLY SIRONA Inc (NASDAQ:XRAY) will post earnings of $0.54 per share for the current quarter, Zacks reports. Seven analysts have made estimates for DENTSPLY SIRONA’s earnings, with estimates ranging from $0.52 to $0.56. DENTSPLY SIRONA posted earnings per share of $0.82 in the same quarter last year, which indicates a negative year-over-year growth rate of 34.1%. The firm is expected to announce its next earnings report on Thursday, March 7th.

According to Zacks, analysts expect that DENTSPLY SIRONA will report full year earnings of $1.97 per share for the current fiscal year, with EPS estimates ranging from $1.95 to $1.98. For the next fiscal year, analysts forecast that the firm will post earnings of $2.17 per share, with EPS estimates ranging from $2.00 to $2.34. Zacks’ EPS calculations are a mean average based on a survey of research analysts that follow DENTSPLY SIRONA.

DENTSPLY SIRONA (NASDAQ:XRAY) last announced its earnings results on Thursday, November 8th. The medical instruments supplier reported $0.38 earnings per share (EPS) for the quarter, missing the Zacks’ consensus estimate of $0.46 by ($0.08). DENTSPLY SIRONA had a positive return on equity of 8.68% and a negative net margin of 41.97%. The company had revenue of $928.40 million for the quarter, compared to analyst estimates of $951.58 million. During the same quarter in the previous year, the company posted $0.70 earnings per share. DENTSPLY SIRONA’s revenue for the quarter was down 8.0% on a year-over-year basis.



XRAY has been the topic of a number of research reports. Goldman Sachs Group upgraded shares of DENTSPLY SIRONA from a “sell” rating to a “buy” rating and set a $44.00 target price on the stock in a research report on Friday, October 19th. BidaskClub lowered shares of DENTSPLY SIRONA from a “hold” rating to a “sell” rating in a report on Thursday, September 27th. Barrington Research restated a “hold” rating on shares of DENTSPLY SIRONA in a report on Friday, November 9th. ValuEngine upgraded shares of DENTSPLY SIRONA from a “strong sell” rating to a “sell” rating in a report on Wednesday, October 24th. Finally, UBS Group began coverage on shares of DENTSPLY SIRONA in a report on Thursday, January 17th. They issued a “neutral” rating and a $42.00 price objective on the stock. One investment analyst has rated the stock with a sell rating, ten have given a hold rating, six have assigned a buy rating and one has given a strong buy rating to the company. The stock currently has a consensus rating of “Hold” and an average price target of $50.62.

In other DENTSPLY SIRONA news, insider Markus Boehringer sold 7,373 shares of the company’s stock in a transaction that occurred on Monday, December 3rd. The shares were sold at an average price of $37.86, for a total value of $279,141.78. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Corporate insiders own 1.93% of the company’s stock.

Large investors have recently modified their holdings of the business. Bank of Montreal Can increased its stake in DENTSPLY SIRONA by 65.8% in the third quarter. Bank of Montreal Can now owns 388,396 shares of the medical instruments supplier’s stock valued at $14,658,000 after purchasing an additional 154,125 shares in the last quarter. QUANTRES ASSET MANAGEMENT Ltd bought a new stake in DENTSPLY SIRONA in the third quarter valued at approximately $577,000. NuWave Investment Management LLC increased its stake in DENTSPLY SIRONA by 22,360.0% in the third quarter. NuWave Investment Management LLC now owns 3,369 shares of the medical instruments supplier’s stock valued at $127,000 after purchasing an additional 3,354 shares in the last quarter. SG Americas Securities LLC increased its stake in DENTSPLY SIRONA by 459.2% in the third quarter. SG Americas Securities LLC now owns 116,189 shares of the medical instruments supplier’s stock valued at $4,385,000 after purchasing an additional 95,413 shares in the last quarter. Finally, Qube Research & Technologies Ltd bought a new stake in DENTSPLY SIRONA in the second quarter valued at approximately $134,000. 97.00% of the stock is owned by hedge funds and other institutional investors.

Shares of XRAY stock traded down $0.28 during trading hours on Thursday, reaching $40.55. 55,546 shares of the company were exchanged, compared to its average volume of 1,851,598. DENTSPLY SIRONA has a fifty-two week low of $33.93 and a fifty-two week high of $63.03. The firm has a market capitalization of $9.09 billion, a price-to-earnings ratio of 15.18, a PEG ratio of 2.26 and a beta of 1.00. The company has a current ratio of 1.76, a quick ratio of 1.14 and a debt-to-equity ratio of 0.31.

The firm also recently disclosed a quarterly dividend, which was paid on Friday, January 11th. Investors of record on Friday, December 28th were issued a $0.0875 dividend. The ex-dividend date of this dividend was Thursday, December 27th. This represents a $0.35 annualized dividend and a yield of 0.86%. DENTSPLY SIRONA’s dividend payout ratio is currently 13.16%.

About DENTSPLY SIRONA

DENTSPLY SIRONA Inc designs, develops, manufactures, and markets various dental and oral health products, and other consumable healthcare products primarily for the professional dental market worldwide. The company operates in two segments, Technologies & Equipment; and Consumables. Its dental supplies include endodontic instruments and materials, dental anesthetics, prophylaxis pastes, dental sealants, impression materials, restorative materials, tooth whiteners, and topical fluoride products; and small equipment products comprise dental hand pieces, intraoral curing light systems, dental diagnostic systems, and ultrasonic scalers and polishers.

See Also: Do Tariffs Work?

Get a free copy of the Zacks research report on DENTSPLY SIRONA (XRAY)

For more information about research offerings from Zacks Investment Research, visit Zacks.com

Earnings History and Estimates for DENTSPLY SIRONA (NASDAQ:XRAY)

Receive News & Ratings for DENTSPLY SIRONA Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for DENTSPLY SIRONA and related companies with MarketBeat.com's FREE daily email newsletter.



Leave a Reply